Book contents
- Frontmatter
- Preface
- Contents
- CME Information
- Objectives
- Chapter 1 Neurobiology of Depression
- Chapter 2 Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Chapter 3 Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs) and Selective Norepinephrine Reuptake Inhibitors (NRIs)
- Chapter 4 Alpha 2 Antagonists as Serotonin and Norepinephrine Disinhibitors (SNDIs) and Serotonin Antagonist/Reuptake Inhibitors (SARIs)
- Chapter 5 Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
- Chapter 6 Building a Treatment Plan with Novel Treatment and Augmentation Options For Depression
- Chapter 7 Depression in Women: Treating Symptoms Throughout the Life Span
- Chapter 8 Pharmacokinetics and Algorithms to Treat Depression
- Summary
- Abbreviations and Symbols
- Suggested Readings
- Index
- CME: Posttest
Chapter 5 - Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
Published online by Cambridge University Press: 19 October 2021
- Frontmatter
- Preface
- Contents
- CME Information
- Objectives
- Chapter 1 Neurobiology of Depression
- Chapter 2 Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Chapter 3 Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs) and Selective Norepinephrine Reuptake Inhibitors (NRIs)
- Chapter 4 Alpha 2 Antagonists as Serotonin and Norepinephrine Disinhibitors (SNDIs) and Serotonin Antagonist/Reuptake Inhibitors (SARIs)
- Chapter 5 Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
- Chapter 6 Building a Treatment Plan with Novel Treatment and Augmentation Options For Depression
- Chapter 7 Depression in Women: Treating Symptoms Throughout the Life Span
- Chapter 8 Pharmacokinetics and Algorithms to Treat Depression
- Summary
- Abbreviations and Symbols
- Suggested Readings
- Index
- CME: Posttest
Summary
This chapter reviews the classical antidepressants known as monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs). The focus here is on mechanisms of action of these particular classes. The aim of this chapter is to familiarize the reader with these “old-fashioned” but quite powerful options for treating depression.
SSRI: selective serotonin reuptake inhibitors. NDRI: norepinephrine dopamine reuptake inhibitors. SNRI: serotonin norepinephrine reuptake inhibitors. SDA: serotonin dopamine antagonists. α 2 antagonist: alpha 2 antagonists. NRI: selective norepinephrine reuptake inhibitors. TCA: tricyclic antidepressants. SARI: serotonin 2A antagonist/reuptake inhibitors. MAOI: monoamine oxidase inhibitors. 5HT1A: serotonin 1A partial agonists. BZ: benzodiazepines. DPA: dopamine partial agonists. MTHF: L-5-methyl-tetrahydrofolate. T3/T4: thyroid hormone. ECT: electroconvulsive therapy. IPT: interpersonal therapy. VNS: vagus nerve stimulation.
- Type
- Chapter
- Information
- Stahl's Illustrated Antidepressants , pp. 97 - 110Publisher: Cambridge University PressPrint publication year: 2009